After 32 minutes of trading, the OMXS30 index was up 0.85 percent at 3,092.93. During the day, the index has fluctuated between a low of 0.41 percent and a high of 1.10 percent.
The broader OMXSPI was up 0.68 percent.
| Stock | Price Change | Comment |
| Biogaia | 6.6% | Issues positive profit warning for the fourth quarter |
| Inwido | 5.9% | Operating profit in Q4 exceeded expectations, totaling 262 million kronor |
| Addnode | 3.6% | Dividend remains unchanged. Q4 EBITA reached a record high of 298 million kronor |
| Boliden | 3.5% | Operating profit well above expectations. Distributes 11 kronor per share, more than expected. Reports increased mineral reserves |
| Ericsson | 0.5% | Reportedly involved in major contract linked to Donald Trump's "Golden Dome" project |
| Academedia | -0.5% | SEB downgrades to sell |
| Kinnevik | -1.3% | Net asset value per share fell to 129.51 kronor. Halves value in Stegra |
| Astra Zeneca | -1.5% | FDA requires additional information for Saphnelo in subcutaneous form. Datroway receives priority review in the US |
| Cereno Scientific | -2.3% | Expects initial insights from EAP during Q1 |
| Alfa Laval | -2.8% | Adjusted EBITA amounted to 3,237 million kronor in Q4, slightly below expectations. Dividend increased slightly less than expected |
| Vitrolife | -11.8% | Operating profit was impacted as expected by a major write-down. Dividend remains unchanged |
| Fasadgruppen | -21.3% | Proposes rights issue of 504 million kronor, increased revenue but decreased net profit in Q4 |
